X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
ORCHID PHARMA LTD Announces Quarterly Results (2QFY19); Net Profit Up 67.1%

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ORCHID PHARMA LTD Announces Quarterly Results (2QFY19); Net Profit Up 67.1%
Thu, 31 Jan

ORCHID PHARMA LTD has announced its results for the quarter ended September 2018. Here is a detailed performance review of the same:

ORCHID PHARMA LTD Quarterly Financials

No. of Mths
Qtr. Ending
3
Sep-17*
3
Jun-18*
3
Sep-18*
QoQ ChangeYoY Change
Net SalesRs m2,0931,3061,4259.1%-31.9%
Other incomeRs m47436347.1%33.1%
TurnoverRs m2,1411,3491,48810.3%-30.5%
ExpensesRs m1,8561,4491,4570.6%-21.5%
Gross profitRs m238-3935-85.1%
DepreciationRs m3363283300.5%-2.0%
InterestRs m7551350-100.0%-100.0%
Profit before taxRs m-806-460-231
TaxRs m-10300-200.0%
Profit after taxRs m-703-460-231
Gross profit margin%11.4-3.02.5
Effective tax rate%12.70.00.0
Net profit margin%-32.9-34.1-15.5
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster


Year-on-Year Performance:
  • The company's operating income during the quarter fell 31.9% on a year-on-year (YoY) basis. The expenses were down by 21.5% YoY during the same period.
  • The company's operating profit declined by 85.1% YoY during the quarter. Consequently, operating profit margins witnessed a decline and stood at 2.5% in 2QFY19 as against 11.4% in 2QFY18.
  • Depreciation charges declined by 2.0% and finance costs declined by 100.0% YoY, respectively.
  • Other income increased by 33.1% YoY during the quarter.
  • Net profit for the quarter increased by 67.1% YoY. Net profit margins during the quarter increased from -32.9% in 2QFY18 to -15.5% in 2QFY19.
Quarter-on-Quarter Performance:
  • The company's operating income during the quarter grew 9.1% on a quarter-on-quarter (QoQ) basis. The expenses were up by 0.6% QoQ during the same period.
  • The company's operating profit increased by 190.2% QoQ during the quarter. Consequently, operating profit margins witnessed a growth and stood at 2.5% in 2QFY19 as against 3.0% in 1QFY18.
  • Net profit for the quarter increased by 49.7% QoQ, while net profit margins increased from -34.1% in 1QFY18 to -15.5% in 2QFY19.

To see how ORCHID PHARMA LTD has performed over the last eight quarters, please visit here.

ORCHID PHARMA LTD Share Price Performance

Over the last one year, ORCHID PHARMA LTD share price has moved up from Rs 17.7 to Rs 4.3, registering a Loss of Rs 13.4 or around 75.8%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 13,860.8 (up 0.7%). Over the last one year it has moved down from 14,559.4 to 13,860.8, a gain of 699 points (down 4.8%).

Overall, the S&P BSE SENSEX is up 0.4% over the year.

Current Valuations

At the current price of Rs 4.3, the price to book value (P/BV) ratio of ORCHID PHARMA LTD stands at 0.1 times.

Equitymaster requests your view! Post a comment on "ORCHID PHARMA LTD Announces Quarterly Results (2QFY19); Net Profit Up 67.1%". Click here!

  

Related Views on News

ORCHID PHARMA LTD Announces Quarterly Results (4QFY18); Net Profit Up 50.8% (Quarterly Result Update)

Aug 24, 2018 | Updated on Aug 24, 2018

For the quarter ended March 2018, ORCHID PHARMA LTD has posted a net profit of Rs 924 m (up 50.8% YoY). Sales on the other hand came in at Rs 2 bn (down 24.0% YoY). Read on for a complete analysis of ORCHID PHARMA LTD's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

Eris Lifesciences Limited (IPO)

Jun 15, 2017

Exposure to high margin specialty products offers promising growth prospects.

More Views on News

Most Popular

This is Why the Stock of Jubilant FoodWorks Went Up 1,160%(The 5 Minute Wrapup)

Apr 12, 2019

This critical business strategy has enabled companies to scale their operations faster.

Pocketing Massive Gains with HDFC And HDFC Bank(Profit Hunter)

Apr 12, 2019

Here's how one could have generated gains of Rs 59,250 in 10 days by trading HDFC and HDFC Bank with a capital of Rs 4 lakh.

A Simple 3-Point Investing Manifesto for You the Indian Investor(The 5 Minute Wrapup)

Apr 11, 2019

A must have checklist for every investor in the Indian stock market.

My Master Series on How to Trade Election 2019(Profit Hunter)

Apr 16, 2019

For 30 years he has watched how elections impact the markets, and practiced how to profit from it. Now he is here...telling you everything. Read on...

Election Series: Follow the World's Biggest Traders To See Where the Money Flows(The 5 Minute Wrapup)

Apr 17, 2019

20% of all the traders bring in 80% of the money. Watch these 20% and you get a working idea of which way the wind is blowing.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

ORCHID PHARMA LTD SHARE PRICE


Apr 24, 2019 (Close)

TRACK ORCHID PHARMA LTD

  • Track your investment in ORCHID PHARMA LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ORCHID PHARMA LTD

ORCHID PHARMA LTD - MYLAN COMPARISON

COMPARE ORCHID PHARMA LTD WITH

MARKET STATS